PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 10 days 18 hours 42 minutes
Scoping Out Optimal Antiviral Therapy for Patients With COVID-19: Exploring the Implications of the Latest Data
Scoping Out Optimal Antiviral Therapy for Patients With COVID-19: Exploring the Implications of the Latest Data
Conversations in Cardiology: Improving Recognition and Management of Hypertrophic Cardiomyopathy
Conversations in Cardiology: Improving Recognition and Management of Hypertrophic Cardiomyopathy
Novel Targets in T2DM: Incretin Co-Agonists to the Rescue?
Novel Targets in T2DM: Incretin Co-Agonists to the Rescue?
Going Below the Surface in Advanced Basal Cell Carcinoma: Analysing the Latest Evidence
Going Below the Surface in Advanced Basal Cell Carcinoma: Analysing the Latest Evidence
Innovation in Antibody Drug-Conjugate Engineering: Will It Pay Off?
Innovation in Antibody Drug-Conjugate Engineering: Will It Pay Off?
Practicalities in the Management of Hypertrophic Cardiomyopathy: A Case-Based Approach
Practicalities in the Management of Hypertrophic Cardiomyopathy: A Case-Based Approach
Individualising Glycaemic Targets in Type 2 Diabetes and Obesity: A Case-Based Approach
Individualising Glycaemic Targets in Type 2 Diabetes and Obesity: A Case-Based Approach
Taking the Sting Out of Hyperkalaemia: What Clinicians Can Do Now
Taking the Sting Out of Hyperkalaemia: What Clinicians Can Do Now
Managing Risk of Persistent Acute Kidney Injury in the ICU: The RUBY Study
Managing Risk of Persistent Acute Kidney Injury in the ICU: The RUBY Study
State of the Science in CKD: New Treatment, New Outcomes
State of the Science in CKD: New Treatment, New Outcomes